Category: Investor updates

Imagion Biosystems has lodged the announcement “Pro-Rata Non-Renounceable Rights Issue” with the Australian Securities Exchange. View the announcement “Pro-Rata Non-Renounceable Rights Issue.”

Imagion Biosystems has lodged Notice to Optionholders — Pro-Rata Non-Renounceable Rights Issue. View the Notice to Optionholders.

Imagion Biosystems has lodged Pro-Rata Non-Renounceable Rights Issue: Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth) with the Australian Securities Exchange. View the Pro-Rata non-Renounceable

Imagion Biosystems has lodged Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. View Appendix 3B.

Imagion Biosystems Limited has lodged a Rights Issue Offer Document with the Australian Securities Exchange. View the Rights Issue Offer Document.

The suspension of trading in the securities of Imagion Biosystems Limited (‘IBX’) will be lifted immediately, following the release by IBX of an announcement regarding

Imagion Biosystems Limited (ASX: IBX) (Imagion or the Company) is pleased to announce a pro-rata non- renounceable rights issue (Offer) to shareholders, on the basis

The securities of Imagion Biosystems Limited (‘IBX’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of IBX, pending the release

The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement. Unless ASX